Dual Targeting With The Selective Histone Deacetylase (HDAC) 6 Inhibitor, ACY-1215, and Bortezomib (BOR) Leads To Marked Disruption Of Protein Degradation Pathways and Apoptosis In Preclinical Models Of Lymphoma
| Image |  |
|---|---|
| Description | scholarly article |
| Author/s |
author: Owen A. O'Connor |
| Publication date | November 15, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work |
https://ashpublications.org/blood/article/122/21/648/70881/Dual-Targeting-With-The-Selective-Histone |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |